Cardiac magnetic resonance based evaluation of aortic stiffness and epicardial fat volume in patients with hypertension,diabetes mellitus,and myocardial infarction

Abstract

Background

Aortic stiffness and epicardial fat relate to cardiovascular risk. Their relationship with each other and their role with hypertension, diabetes mellitus (DM), and myocardial infarction (MI) can be evaluated by cardiac magnetic resonance (CMR).

Purpose

To explore an association between aortic stiffness and epicardial as well as paracardial fat volume (EFV and ParaFV, respectively) in hypertensive patients and to relate the results to the presence of DM and MI.

Material and Methods

A total of 156 hypertensive and 20 non-hypertensive participants were examined at 1.5 Tesla. A 2D-velocity-encoded sequence was acquired to assess aortic pulse wave velocity (PWV in m/s) as a measure of aortic stiffness. A 3D-Dixon sequence was used to determine EFV and ParaFV.

Results

PWV correlated with EFV (R = 0.474; P < 0.001), but not with ParaFV. Fat volumes (in mL/m²) and PWV were lower in non-hypertensive controls compared to hypertensive patients. EFV and PWV were significantly higher in diabetic hypertensive patients without MI (n = 19; PWV: 10.4 ± 2.9; EFV: 92.5 ± 19.3) compared to hypertension-only patients (n = 84 [no DM or MI]; EFV: 64.8 ± 25.1, PWV: 9.0 ± 2.6; P < 0.05). Logistic regression analysis showed a significant association between the presence of a MI and a higher EFV (P < 0.05), but not with PWV (P = 0.060) or ParaFV (P = 0.375).

Conclusion

A relationship between aortic stiffness and EFV was found in hypertensive patients. Both were increased in the presence of DM; however, only EFV was increased in the presence of MI. This may relate to the PWV lowering effect of the antihypertensive medication used by hypertensive patients and underscores the benefit of EFV assessment in this regard.

Keywords

Epicardial fat aortic stiffness hypertension diabetes mellitus myocardial infarction cardiac magnetic resonance

Get full access to this article

View all access options for this article.

References

Talman

Psaltis

Cameron

et al.

Epicardial adipose tissue: far more than a fat depot. Cardiovasc Diagn Ther 2014; 4: 416–429.

Laurent

Cockcroft

Van Bortel

et al.

Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27: 2588–2605.

Baulmann

Homsi

Uen

et al.

Pulse wave velocity is increased in patients with transient myocardial ischemia. J Hypertens 2006; 24: 2085–2090.

Dudenbostel

Glasser

. Effects of antihypertensive drugs on arterial stiffness. Cardiol Rev 2012; 20: 259–263.

Homsi

Thomas

Gieseke

et al.

Epicardial fat volume and aortic stiffness in healthy individuals: a quantitative cardiac magnetic resonance study. Rofo 2016; 188: 853–858.

Kim

Kang

. Echocardiographic epicardial fat thickness is associated with coronary artery calcification- results from the CAESAR Study. Circ J 2015; 79: 818–824.

Homsi

Meier-Schroers

Gieseke

et al.

3D-Dixon MRI based volumetry of peri- and epicardial fat. Int J Cardiovasc Imaging 2016; 32: 291–299.

Wentland

Grist

Wieben

. Review of MRI-based measurements of pulse wave velocity: a biomarker of arterial stiffness. Cardiovasc Diagn Ther 2014; 4: 193–206.

Look

Locker

. Time saving in measurement of NMR and EPR relaxation times. Review of Scientific Instruments 1970; 41: 250–251.

10.

McConnell

Khasgiwala

Savord

et al.

Prospective adaptive navigator correction for breath-hold MR coronary angiography. Magn Reson Med 1997; 37: 148–152.

11.

Eggers

Brendel

Duijndam

et al.

Dual-echo Dixon imaging with flexible choice of echo times. Magn Reson Med 2011; 65: 96–107.

12.

Yusuf

Hawken

Ounpuu

et al.

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937–952.

13.

Lyons

Basu

. Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers. Transl Res 2012; 159: 303–312.

14.

Saely

Rein

Vonbank

et al.

Type 2 diabetes and the progression of visualized atherosclerosis to clinical cardiovascular events. Int J Cardiol 2013; 167: 776–780.

15.

Libby

. Inflammation in atherosclerosis. Nature 2002; 420: 868–874.

16.

Iacobellis

Bianco

. Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends Endocrinol Metab 2011; 22: 450–457.

17.

Ferreira

Snijder

Twisk

et al.

Central fat mass versus peripheral fat and lean mass: opposite (adverse versus favorable) associations with arterial stiffness? The Amsterdam Growth and Health Longitudinal Study. J Clin Endocrinol Metab 2004; 89: 2632–2639.

18.

Marchington

Pond

. Site-specific properties of pericardial and epicardial adipose tissue: the effects of insulin and high-fat feeding on lipogenesis and the incorporation of fatty acids in vitro. Int J Obes 1990; 14: 1013–1022.

19.

Shimabukuro

Hirata

Tabata

et al.

Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 2013; 33: 1077–1084.

20.

Karastergiou

Evans

Ogston

et al.

Epicardial adipokines in obesity and coronary artery disease induce atherogenic changes in monocytes and endothelial cells. Arterioscler Thromb Vasc Biol 2010; 30: 1340–1346.

21.

Mazurek

Zhang

Zalewski

et al.

Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003; 108: 2460–2466.

22.

Hirata

Tabata

Kurobe

et al.

Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J Am Coll Cardiol 2011; 58: 248–255.

23.

Harada

Uetani

et al.

The different association of epicardial fat with coronary plaque in patients with acute coronary syndrome and patients with stable angina pectoris: analysis using integrated backscatter intravascular ultrasound. Atherosclerosis 2014; 236: 301–306.

24.

Schlett

Ferencik

Kriegel

et al.

Association of pericardial fat and coronary high-risk lesions as determined by cardiac CT. Atherosclerosis 2012; 222: 129–134.

25.

Homsi

Sprinkart

Gieseke

et al.

3D-Dixon cardiac magnetic resonance detects an increased epicardial fat volume in hypertensive men with myocardial infarction. Eur J Radiol 2016; 85: 936–942.

26.

Park

Kim

et al.

Effects of statins on the epicardial fat thickness in patients with coronary artery stenosis underwent percutaneous coronary intervention: comparison of atorvastatin with simvastatin/ezetimibe. J Cardiovasc Ultrasound 2010; 18: 121–126.